XORTX Therapeutics

XRTX50

Penny Stock

$1.23arrow_drop_down4.15%-$0.05

Penny Stock

XRTX50

$1.23

arrow_drop_down4.15%-$0.05

Penny Stock

Performance History

Key Stats
Open	$1.27
Prev. Close	$1.28
EPS	-0.37
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$4.15M
PE Ratio	-

	LOW	HIGH
Day Range	1.27	1.27
52 Week Range	0.25	29.80

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.37

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc. (XRTX) is a biopharmaceutical company that focuses on the development of innovative therapies for the treatment of kidney diseases, including polycystic kidney disease (PKD) and autosomal dominant polycystic kidney disease (ADPKD). With a dedicated team of scientists and researchers, XORTX is at the forefront of discovering novel treatment options that could potentially improve the lives of millions of patients suffering from these debilitating conditions.

As of the latest market close, XORTX Therapeutics Inc. (XRTX) had a stock price of $10.50 per share. Over the past year, the stock has experienced significant volatility, with a 52-week range of $5.75 to $14.50. This demonstrates the potential for both growth and risk associated with investing in XRTX. It is important for investors to carefully analyze the company's financial performance and market positioning before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Allen Warren Davidoff Ph.D.
Headquarters: Alberta Beach
Employees: 3
Exchange: NASDAQ

Keep an eye on XORTX Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is XORTX Therapeutics's (XRTX) price per share?

The current price per share for XORTX Therapeutics (XRTX) is $1.23. The stock has seen a price change of -$0.05 recently, indicating a -4.15% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for XORTX Therapeutics (XRTX)?

For XORTX Therapeutics (XRTX), the 52-week high is $29.81, which is 2.32K% from the current price. The 52-week low is $0.25, the current price is 393.68% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is XORTX Therapeutics (XRTX) a growth stock?

XORTX Therapeutics (XRTX) has shown an average price growth of -6.8% over the past three years. It has received a score of 82 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying XORTX Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is XORTX Therapeutics (XRTX) stock price performance year to date (YTD)?

As of the latest data, XORTX Therapeutics (XRTX) has a year-to-date price change of -43.9%. Over the past month, the stock has experienced a price change of -34.35%. Over the last three months, the change has been -13.69%. Over the past six months, the figure is -49.95%.

help

Is XORTX Therapeutics (XRTX) a profitable company?

XORTX Therapeutics (XRTX) has a net income of -$2.16M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$6.57M. Furthermore, the EBITDA is -$3.3M.

help

What is the market capitalization of XORTX Therapeutics (XRTX)?

XORTX Therapeutics (XRTX) has a market capitalization of $3.98M. The average daily trading volume is 1.28, indicating the stock's liquidity and investor engagement.